Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Farnesyltranstransferase | 7 | 2021 | 85 | 2.780 |
Why?
|
Nitric Oxide Synthase Type II | 14 | 2018 | 562 | 2.660 |
Why?
|
Burns | 20 | 2019 | 1790 | 2.190 |
Why?
|
Muscle, Skeletal | 25 | 2021 | 4931 | 1.990 |
Why?
|
Muscular Atrophy | 4 | 2020 | 319 | 1.480 |
Why?
|
Sepsis | 9 | 2021 | 2465 | 1.350 |
Why?
|
Insulin Resistance | 20 | 2015 | 3884 | 1.210 |
Why?
|
Nitric Oxide Donors | 5 | 2011 | 125 | 1.190 |
Why?
|
Sirtuin 1 | 5 | 2017 | 303 | 1.170 |
Why?
|
Transcription Factor RelA | 3 | 2018 | 291 | 1.070 |
Why?
|
Ubiquinone | 2 | 2019 | 193 | 1.060 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2017 | 620 | 1.040 |
Why?
|
Vitamin K | 6 | 2009 | 286 | 1.000 |
Why?
|
Protein Prenylation | 4 | 2017 | 79 | 0.960 |
Why?
|
Methionine | 4 | 2021 | 611 | 0.940 |
Why?
|
Mitochondria | 7 | 2021 | 3613 | 0.920 |
Why?
|
Enzyme Inhibitors | 9 | 2018 | 3897 | 0.830 |
Why?
|
Glycogen Synthase Kinase 3 | 4 | 2012 | 440 | 0.790 |
Why?
|
Cachexia | 2 | 2020 | 183 | 0.760 |
Why?
|
Protective Agents | 1 | 2021 | 162 | 0.750 |
Why?
|
Insulin-Secreting Cells | 3 | 2013 | 972 | 0.750 |
Why?
|
Insulin Receptor Substrate Proteins | 9 | 2015 | 586 | 0.750 |
Why?
|
Myostatin | 1 | 2020 | 119 | 0.750 |
Why?
|
Hyperglycemia | 6 | 2011 | 1356 | 0.700 |
Why?
|
Caspase 3 | 7 | 2015 | 795 | 0.680 |
Why?
|
Simvastatin | 5 | 2015 | 361 | 0.680 |
Why?
|
Insulin | 12 | 2019 | 6648 | 0.680 |
Why?
|
Apoptosis | 20 | 2018 | 9971 | 0.660 |
Why?
|
Vitamin K 2 | 5 | 2006 | 44 | 0.650 |
Why?
|
Nitric Oxide Synthase | 7 | 2013 | 938 | 0.620 |
Why?
|
Heat-Shock Proteins | 1 | 2020 | 829 | 0.580 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 794 | 0.570 |
Why?
|
Enzyme Activation | 12 | 2017 | 3818 | 0.550 |
Why?
|
Shock | 1 | 2017 | 317 | 0.550 |
Why?
|
Mice, Inbred C57BL | 32 | 2019 | 22663 | 0.550 |
Why?
|
Multiple Organ Failure | 1 | 2017 | 377 | 0.540 |
Why?
|
Nitrogen | 2 | 2014 | 341 | 0.540 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2946 | 0.540 |
Why?
|
Hypoglycemic Agents | 4 | 2013 | 2774 | 0.530 |
Why?
|
Lysine | 2 | 2012 | 1029 | 0.530 |
Why?
|
Nitric Oxide | 9 | 2018 | 2123 | 0.500 |
Why?
|
Cytoprotection | 2 | 2015 | 216 | 0.500 |
Why?
|
Animals | 84 | 2021 | 169404 | 0.500 |
Why?
|
Mice | 55 | 2021 | 80373 | 0.490 |
Why?
|
Diabetes Mellitus, Experimental | 3 | 2018 | 1205 | 0.450 |
Why?
|
Muscles | 1 | 2017 | 1556 | 0.450 |
Why?
|
Signal Transduction | 18 | 2019 | 23729 | 0.430 |
Why?
|
Benzylidene Compounds | 3 | 2017 | 35 | 0.430 |
Why?
|
Osteoporosis | 5 | 2008 | 1563 | 0.420 |
Why?
|
Niacinamide | 1 | 2013 | 428 | 0.420 |
Why?
|
Osteoblasts | 8 | 2009 | 1185 | 0.410 |
Why?
|
Bacterial Load | 1 | 2011 | 158 | 0.410 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2011 | 121 | 0.400 |
Why?
|
Phosphorylation | 15 | 2020 | 8657 | 0.400 |
Why?
|
Interleukin-15 | 1 | 2011 | 162 | 0.390 |
Why?
|
Endotoxemia | 3 | 2014 | 218 | 0.380 |
Why?
|
Proto-Oncogene Proteins c-akt | 9 | 2015 | 2555 | 0.370 |
Why?
|
Bone and Bones | 6 | 2008 | 2567 | 0.370 |
Why?
|
Receptors, Estrogen | 3 | 2016 | 2167 | 0.360 |
Why?
|
Inflammation | 5 | 2017 | 10082 | 0.360 |
Why?
|
Liver | 7 | 2015 | 7594 | 0.360 |
Why?
|
Osteocalcin | 1 | 2009 | 276 | 0.350 |
Why?
|
Phosphoproteins | 5 | 2007 | 2538 | 0.340 |
Why?
|
Critical Illness | 2 | 2013 | 2529 | 0.340 |
Why?
|
Physical Endurance | 1 | 2011 | 386 | 0.330 |
Why?
|
Polyunsaturated Alkamides | 1 | 2007 | 25 | 0.320 |
Why?
|
Polyenes | 1 | 2007 | 74 | 0.320 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2011 | 1312 | 0.310 |
Why?
|
Running | 1 | 2011 | 459 | 0.300 |
Why?
|
Intensive Care Units | 3 | 2015 | 3451 | 0.300 |
Why?
|
Naphthols | 1 | 2006 | 50 | 0.290 |
Why?
|
Osteoporosis, Postmenopausal | 3 | 2001 | 391 | 0.290 |
Why?
|
Blood Glucose | 4 | 2011 | 6258 | 0.290 |
Why?
|
Cell Death | 1 | 2011 | 1724 | 0.280 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 2 | 2004 | 78 | 0.270 |
Why?
|
Penicillamine | 1 | 2005 | 65 | 0.270 |
Why?
|
Disease Models, Animal | 13 | 2019 | 18197 | 0.270 |
Why?
|
Spinal Cord Ischemia | 2 | 2018 | 82 | 0.260 |
Why?
|
Paraplegia | 2 | 2018 | 169 | 0.260 |
Why?
|
Imidazoles | 1 | 2011 | 1249 | 0.260 |
Why?
|
Oxidative Stress | 4 | 2014 | 3129 | 0.260 |
Why?
|
Exercise | 2 | 2020 | 5427 | 0.260 |
Why?
|
Hydrogen Sulfide | 2 | 2018 | 142 | 0.260 |
Why?
|
Muscular Disorders, Atrophic | 2 | 2015 | 29 | 0.250 |
Why?
|
Muscle Cells | 1 | 2005 | 199 | 0.250 |
Why?
|
Rats | 22 | 2016 | 24852 | 0.250 |
Why?
|
Lipopolysaccharides | 5 | 2014 | 2242 | 0.240 |
Why?
|
Muscle Proteins | 2 | 2020 | 1152 | 0.240 |
Why?
|
Phosphatidylinositol 3-Kinases | 8 | 2011 | 2939 | 0.240 |
Why?
|
Up-Regulation | 3 | 2015 | 4312 | 0.240 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 722 | 0.230 |
Why?
|
Apolipoproteins E | 2 | 2007 | 1442 | 0.230 |
Why?
|
Indoles | 1 | 2011 | 1842 | 0.230 |
Why?
|
Acetylation | 2 | 2017 | 1103 | 0.230 |
Why?
|
Genes, ras | 1 | 2006 | 706 | 0.230 |
Why?
|
MAP Kinase Kinase Kinase 1 | 2 | 2000 | 58 | 0.230 |
Why?
|
Mitogen-Activated Protein Kinases | 5 | 2000 | 1311 | 0.220 |
Why?
|
Quinolones | 2 | 2016 | 400 | 0.220 |
Why?
|
Immobilization | 4 | 2014 | 250 | 0.220 |
Why?
|
Spleen | 3 | 2015 | 2464 | 0.210 |
Why?
|
Male | 50 | 2021 | 350352 | 0.210 |
Why?
|
Vitamin K 1 | 3 | 2006 | 45 | 0.200 |
Why?
|
Soybeans | 1 | 2001 | 86 | 0.200 |
Why?
|
Hepatocytes | 4 | 2014 | 1238 | 0.200 |
Why?
|
Muscular Dystrophy, Animal | 2 | 2013 | 104 | 0.200 |
Why?
|
Lipolysis | 2 | 2015 | 218 | 0.200 |
Why?
|
Mice, Knockout | 11 | 2018 | 15058 | 0.200 |
Why?
|
Reperfusion Injury | 2 | 2018 | 1067 | 0.190 |
Why?
|
Vitamin K Deficiency | 3 | 2008 | 27 | 0.190 |
Why?
|
HMGB1 Protein | 2 | 2011 | 140 | 0.190 |
Why?
|
NF-kappa B | 3 | 2015 | 2553 | 0.190 |
Why?
|
Tyrosine | 4 | 2011 | 1506 | 0.190 |
Why?
|
Neuroprotective Agents | 2 | 2018 | 995 | 0.190 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 501 | 0.190 |
Why?
|
Parkinson Disease | 2 | 2011 | 2680 | 0.190 |
Why?
|
Benzamides | 1 | 2006 | 1390 | 0.190 |
Why?
|
Glucose Tolerance Test | 3 | 2011 | 1153 | 0.190 |
Why?
|
Femoral Neck Fractures | 1 | 2001 | 141 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8571 | 0.190 |
Why?
|
Phosphodiesterase 5 Inhibitors | 2 | 2013 | 110 | 0.180 |
Why?
|
Pyridines | 3 | 2017 | 2846 | 0.180 |
Why?
|
Liver Function Tests | 1 | 2020 | 534 | 0.180 |
Why?
|
Myocytes, Cardiac | 3 | 2015 | 1630 | 0.180 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2015 | 712 | 0.170 |
Why?
|
Adipocytes | 3 | 2015 | 1173 | 0.170 |
Why?
|
COS Cells | 2 | 2014 | 1201 | 0.170 |
Why?
|
Myoblasts, Skeletal | 2 | 2017 | 91 | 0.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2010 | 3149 | 0.170 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 4 | 2015 | 466 | 0.170 |
Why?
|
Neutrophil Infiltration | 1 | 2020 | 400 | 0.170 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2017 | 40 | 0.160 |
Why?
|
Interleukin-6 | 4 | 2017 | 3171 | 0.160 |
Why?
|
Glucose Transporter Type 1 | 1 | 2017 | 190 | 0.160 |
Why?
|
Isoenzymes | 2 | 2000 | 1803 | 0.160 |
Why?
|
Protein Kinase C | 2 | 2000 | 1269 | 0.160 |
Why?
|
Glycyrrhizic Acid | 1 | 2016 | 12 | 0.160 |
Why?
|
S-Nitrosoglutathione | 2 | 2018 | 25 | 0.150 |
Why?
|
Receptor, Insulin | 4 | 2011 | 868 | 0.150 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2017 | 567 | 0.150 |
Why?
|
Monocytes | 2 | 1999 | 2620 | 0.150 |
Why?
|
Receptors, Nicotinic | 2 | 2012 | 488 | 0.150 |
Why?
|
Muscle Weakness | 1 | 2019 | 406 | 0.150 |
Why?
|
Cell Migration Assays, Leukocyte | 1 | 2016 | 9 | 0.150 |
Why?
|
Mitochondrial Diseases | 1 | 2019 | 314 | 0.150 |
Why?
|
Shock, Septic | 3 | 2015 | 726 | 0.150 |
Why?
|
STAT3 Transcription Factor | 1 | 2020 | 891 | 0.150 |
Why?
|
Sarcopenia | 1 | 2020 | 308 | 0.150 |
Why?
|
Aorta | 1 | 2004 | 2076 | 0.150 |
Why?
|
Indazoles | 1 | 2017 | 291 | 0.140 |
Why?
|
Autophagy | 2 | 2015 | 1314 | 0.140 |
Why?
|
Glucose | 7 | 2017 | 4270 | 0.140 |
Why?
|
MAP Kinase Kinase 4 | 2 | 2009 | 147 | 0.140 |
Why?
|
Sulfites | 1 | 2015 | 95 | 0.140 |
Why?
|
Myocardium | 7 | 2015 | 4909 | 0.140 |
Why?
|
Thiosulfates | 1 | 2015 | 58 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2015 | 4454 | 0.140 |
Why?
|
Galactosamine | 1 | 2014 | 29 | 0.140 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2016 | 315 | 0.140 |
Why?
|
Calcitriol | 2 | 1994 | 309 | 0.140 |
Why?
|
Cell Line, Tumor | 6 | 2018 | 16735 | 0.140 |
Why?
|
Hair | 1 | 2018 | 444 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 4647 | 0.130 |
Why?
|
Gene Expression Regulation | 3 | 2018 | 12305 | 0.130 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2015 | 253 | 0.130 |
Why?
|
Atherosclerosis | 2 | 2007 | 3159 | 0.130 |
Why?
|
Maze Learning | 1 | 2016 | 491 | 0.130 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2011 | 100 | 0.130 |
Why?
|
Rats, Sprague-Dawley | 12 | 2012 | 8542 | 0.130 |
Why?
|
Humans | 48 | 2020 | 715818 | 0.130 |
Why?
|
Stress, Psychological | 1 | 2009 | 4164 | 0.130 |
Why?
|
Mice, Transgenic | 7 | 2015 | 9849 | 0.130 |
Why?
|
Carbolines | 2 | 2013 | 256 | 0.120 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 1994 | 197 | 0.120 |
Why?
|
Models, Animal | 1 | 2020 | 2204 | 0.120 |
Why?
|
Rats, Inbred F344 | 1 | 2014 | 878 | 0.120 |
Why?
|
Streptozocin | 1 | 2013 | 202 | 0.120 |
Why?
|
Glutathione Reductase | 1 | 2013 | 30 | 0.120 |
Why?
|
Immunoblotting | 4 | 2017 | 1771 | 0.120 |
Why?
|
Sirtuins | 2 | 2007 | 367 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1597 | 0.120 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2015 | 349 | 0.120 |
Why?
|
Liver Failure, Acute | 1 | 2014 | 175 | 0.120 |
Why?
|
Glycogen Synthase | 1 | 2012 | 63 | 0.120 |
Why?
|
Ubiquitin | 2 | 2010 | 827 | 0.120 |
Why?
|
Tetradecanoylphorbol Acetate | 3 | 2000 | 865 | 0.120 |
Why?
|
Fibrinogen | 1 | 2016 | 919 | 0.120 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2016 | 699 | 0.110 |
Why?
|
Muscle Contraction | 4 | 2015 | 1239 | 0.110 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 814 | 0.110 |
Why?
|
Liver Diseases | 1 | 2020 | 1243 | 0.110 |
Why?
|
PPAR gamma | 1 | 2015 | 482 | 0.110 |
Why?
|
Anesthesia, Intravenous | 1 | 2012 | 135 | 0.110 |
Why?
|
Dietary Fats | 3 | 2015 | 2048 | 0.110 |
Why?
|
Amino Acid Motifs | 1 | 2014 | 967 | 0.110 |
Why?
|
Protein Multimerization | 1 | 2017 | 997 | 0.110 |
Why?
|
Physical Conditioning, Animal | 1 | 2015 | 364 | 0.110 |
Why?
|
Anthracenes | 1 | 2011 | 89 | 0.110 |
Why?
|
Cyclophilin A | 1 | 2011 | 62 | 0.110 |
Why?
|
Leupeptins | 1 | 2011 | 124 | 0.110 |
Why?
|
Triglycerides | 3 | 2015 | 2577 | 0.110 |
Why?
|
Cadherins | 1 | 2016 | 913 | 0.100 |
Why?
|
Cells, Cultured | 11 | 2016 | 19905 | 0.100 |
Why?
|
Hypokinesia | 1 | 2010 | 17 | 0.100 |
Why?
|
Calcium | 6 | 2015 | 5800 | 0.100 |
Why?
|
Antioxidants | 2 | 2011 | 1670 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 1842 | 0.100 |
Why?
|
Anesthetics, Inhalation | 1 | 2016 | 557 | 0.100 |
Why?
|
Mice, Obese | 2 | 2018 | 445 | 0.100 |
Why?
|
Cecum | 1 | 2011 | 233 | 0.100 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2011 | 201 | 0.100 |
Why?
|
Obesity | 4 | 2018 | 12248 | 0.100 |
Why?
|
Heart Function Tests | 1 | 2011 | 331 | 0.100 |
Why?
|
Cholecalciferol | 1 | 2015 | 498 | 0.100 |
Why?
|
Parkinson Disease, Secondary | 1 | 2010 | 127 | 0.100 |
Why?
|
Nicotinic Agonists | 1 | 2012 | 270 | 0.100 |
Why?
|
Cell Line | 7 | 2017 | 16575 | 0.100 |
Why?
|
Acetylcysteine | 1 | 2011 | 275 | 0.090 |
Why?
|
Neuromuscular Junction | 2 | 2014 | 358 | 0.090 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 2913 | 0.090 |
Why?
|
Time Factors | 9 | 2021 | 40887 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2006 | 2091 | 0.090 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2010 | 375 | 0.090 |
Why?
|
Neurotoxins | 1 | 2010 | 240 | 0.090 |
Why?
|
Prostaglandins | 1 | 1990 | 429 | 0.090 |
Why?
|
Free Radical Scavengers | 1 | 2010 | 226 | 0.090 |
Why?
|
Anesthetics, Intravenous | 1 | 2012 | 410 | 0.090 |
Why?
|
Myocardial Contraction | 2 | 2013 | 1639 | 0.090 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2016 | 782 | 0.090 |
Why?
|
Survival Analysis | 2 | 2020 | 10503 | 0.090 |
Why?
|
Cell Proliferation | 3 | 2016 | 10615 | 0.090 |
Why?
|
Regeneration | 1 | 2018 | 1535 | 0.090 |
Why?
|
Substantia Nigra | 1 | 2010 | 357 | 0.090 |
Why?
|
Albumins | 1 | 2011 | 564 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1887 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 1245 | 0.080 |
Why?
|
beta-Galactosidase | 2 | 2007 | 611 | 0.080 |
Why?
|
Microcirculation | 1 | 2013 | 1294 | 0.080 |
Why?
|
Blotting, Western | 6 | 2014 | 5378 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-abl | 2 | 2000 | 154 | 0.080 |
Why?
|
Movement Disorders | 1 | 2011 | 427 | 0.080 |
Why?
|
Random Allocation | 1 | 2012 | 2445 | 0.080 |
Why?
|
U937 Cells | 4 | 2000 | 275 | 0.080 |
Why?
|
Denervation | 2 | 2015 | 267 | 0.080 |
Why?
|
Neuromuscular Nondepolarizing Agents | 2 | 2007 | 149 | 0.080 |
Why?
|
Synaptic Transmission | 1 | 2014 | 1191 | 0.080 |
Why?
|
RNA, Small Interfering | 3 | 2012 | 3574 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 500 | 0.080 |
Why?
|
1-Carboxyglutamic Acid | 1 | 2006 | 21 | 0.080 |
Why?
|
Reactive Oxygen Species | 4 | 2016 | 2099 | 0.080 |
Why?
|
Sinus of Valsalva | 1 | 2007 | 60 | 0.080 |
Why?
|
Propofol | 1 | 2012 | 565 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2006 | 511 | 0.080 |
Why?
|
Soy Foods | 1 | 2006 | 45 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2007 | 205 | 0.070 |
Why?
|
Hyperinsulinism | 1 | 2009 | 412 | 0.070 |
Why?
|
Motor Neurons | 1 | 2011 | 799 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1703 | 0.070 |
Why?
|
Liver Neoplasms | 3 | 2006 | 4102 | 0.070 |
Why?
|
Receptors, Steroid | 1 | 2006 | 157 | 0.070 |
Why?
|
Superoxides | 1 | 2007 | 383 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 9596 | 0.070 |
Why?
|
Carcinoma | 1 | 2017 | 2320 | 0.070 |
Why?
|
Oligopeptides | 1 | 2011 | 1236 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1402 | 0.070 |
Why?
|
Interleukin-1beta | 1 | 2011 | 962 | 0.070 |
Why?
|
Botulinum Toxins | 1 | 2007 | 187 | 0.070 |
Why?
|
Delirium | 1 | 2016 | 1481 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5947 | 0.070 |
Why?
|
3T3 Cells | 2 | 2005 | 1121 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 1785 | 0.070 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2023 | 0.070 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2006 | 295 | 0.070 |
Why?
|
Atrophy | 3 | 2019 | 1499 | 0.070 |
Why?
|
Rats, Inbred WKY | 1 | 2004 | 158 | 0.070 |
Why?
|
Rats, Inbred SHR | 1 | 2004 | 200 | 0.060 |
Why?
|
Injections, Intraperitoneal | 2 | 2018 | 436 | 0.060 |
Why?
|
Diphosphonates | 1 | 2009 | 630 | 0.060 |
Why?
|
Serine | 2 | 2005 | 827 | 0.060 |
Why?
|
Anesthesia | 1 | 2015 | 1515 | 0.060 |
Why?
|
Vitamin D | 2 | 2015 | 3193 | 0.060 |
Why?
|
Tumor Cells, Cultured | 4 | 2010 | 6482 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2013 | 2316 | 0.060 |
Why?
|
Gene Silencing | 1 | 2010 | 1606 | 0.060 |
Why?
|
Hemodynamics | 2 | 2011 | 4214 | 0.060 |
Why?
|
Bungarotoxins | 2 | 2014 | 44 | 0.060 |
Why?
|
Cytokines | 3 | 2015 | 7189 | 0.060 |
Why?
|
Receptor, IGF Type 1 | 1 | 2006 | 397 | 0.060 |
Why?
|
Cardiotonic Agents | 1 | 2006 | 549 | 0.060 |
Why?
|
Anticholesteremic Agents | 1 | 2010 | 960 | 0.060 |
Why?
|
Exercise Test | 1 | 2011 | 2110 | 0.060 |
Why?
|
Neutrophils | 1 | 2016 | 3800 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2015 | 3110 | 0.060 |
Why?
|
Epidermal Growth Factor | 1 | 2006 | 722 | 0.060 |
Why?
|
Neurodegenerative Diseases | 1 | 2011 | 951 | 0.060 |
Why?
|
Aging | 2 | 1999 | 8349 | 0.060 |
Why?
|
Administration, Inhalation | 2 | 2018 | 1106 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2011 | 3250 | 0.060 |
Why?
|
Receptors, Glucocorticoid | 1 | 2004 | 307 | 0.060 |
Why?
|
Coronary Circulation | 1 | 2008 | 1652 | 0.060 |
Why?
|
Estrogens | 1 | 2009 | 1529 | 0.060 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 14161 | 0.050 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 641 | 0.050 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 18591 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1909 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2010 | 2028 | 0.050 |
Why?
|
Bone Density Conservation Agents | 1 | 2009 | 785 | 0.050 |
Why?
|
Warfarin | 2 | 2009 | 1476 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 11090 | 0.050 |
Why?
|
ras Proteins | 1 | 2007 | 1102 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2013 | 1834 | 0.050 |
Why?
|
DNA Damage | 3 | 2000 | 2434 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2015 | 3317 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2005 | 2086 | 0.050 |
Why?
|
Bacillus | 1 | 2001 | 77 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2006 | 7885 | 0.050 |
Why?
|
Fermentation | 1 | 2001 | 145 | 0.050 |
Why?
|
bcl-X Protein | 2 | 2018 | 396 | 0.050 |
Why?
|
Lipid Metabolism | 2 | 2008 | 1990 | 0.050 |
Why?
|
Ventricular Remodeling | 1 | 2008 | 1239 | 0.050 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2006 | 790 | 0.050 |
Why?
|
Arteriosclerosis | 1 | 2005 | 1131 | 0.050 |
Why?
|
Cysteine | 1 | 2005 | 872 | 0.050 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2007 | 1571 | 0.050 |
Why?
|
Ergocalciferols | 2 | 1991 | 116 | 0.050 |
Why?
|
Transfection | 2 | 2007 | 6089 | 0.050 |
Why?
|
Neurons | 2 | 2018 | 9375 | 0.050 |
Why?
|
Caspases | 2 | 2000 | 949 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 6009 | 0.050 |
Why?
|
Japan | 2 | 2001 | 1337 | 0.050 |
Why?
|
Heart Rate | 1 | 2011 | 4096 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9730 | 0.040 |
Why?
|
Fasting | 1 | 2005 | 1594 | 0.040 |
Why?
|
Female | 11 | 2019 | 377229 | 0.040 |
Why?
|
Mitogens | 1 | 1999 | 252 | 0.040 |
Why?
|
Mitochondria, Muscle | 1 | 2019 | 170 | 0.040 |
Why?
|
Osteoclasts | 2 | 1994 | 730 | 0.040 |
Why?
|
Bone Resorption | 3 | 1991 | 737 | 0.040 |
Why?
|
Ischemia | 1 | 2007 | 1906 | 0.040 |
Why?
|
Spinal Fractures | 1 | 2005 | 691 | 0.040 |
Why?
|
HL-60 Cells | 1 | 1999 | 369 | 0.040 |
Why?
|
Cell Division | 5 | 2007 | 4697 | 0.040 |
Why?
|
Adipose Tissue | 2 | 2010 | 3225 | 0.040 |
Why?
|
Anaerobiosis | 1 | 2017 | 141 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 3 | 2006 | 663 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2008 | 1996 | 0.040 |
Why?
|
Cell Movement | 1 | 2010 | 5397 | 0.040 |
Why?
|
Acetyl Coenzyme A | 1 | 2017 | 68 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2018 | 13212 | 0.040 |
Why?
|
Calcinosis | 1 | 2006 | 1453 | 0.040 |
Why?
|
Deoxyguanosine | 1 | 2017 | 89 | 0.040 |
Why?
|
Macrophages | 1 | 2012 | 5742 | 0.040 |
Why?
|
Phenotype | 3 | 2011 | 16311 | 0.040 |
Why?
|
Nitroimidazoles | 1 | 2017 | 117 | 0.040 |
Why?
|
Calcium-Binding Proteins | 2 | 2015 | 1090 | 0.040 |
Why?
|
Administration, Topical | 1 | 2018 | 700 | 0.040 |
Why?
|
Behavior, Animal | 2 | 2016 | 1887 | 0.030 |
Why?
|
Age Factors | 1 | 2013 | 18787 | 0.030 |
Why?
|
Blotting, Northern | 2 | 1994 | 1625 | 0.030 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2015 | 91 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2017 | 484 | 0.030 |
Why?
|
Isoproterenol | 1 | 2015 | 411 | 0.030 |
Why?
|
Adult | 6 | 2015 | 212279 | 0.030 |
Why?
|
Anion Transport Proteins | 1 | 2015 | 141 | 0.030 |
Why?
|
Pentobarbital | 1 | 2015 | 157 | 0.030 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 131 | 0.030 |
Why?
|
Fractures, Bone | 1 | 2006 | 1876 | 0.030 |
Why?
|
Feces | 1 | 2001 | 1378 | 0.030 |
Why?
|
Risk Factors | 4 | 2013 | 70879 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2004 | 2103 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2007 | 4586 | 0.030 |
Why?
|
Calcifediol | 1 | 2015 | 175 | 0.030 |
Why?
|
Conotoxins | 1 | 2014 | 22 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2015 | 11201 | 0.030 |
Why?
|
Crotalid Venoms | 1 | 2014 | 34 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 1994 | 90 | 0.030 |
Why?
|
Parathyroid Hormone | 2 | 1991 | 1820 | 0.030 |
Why?
|
Adrenergic beta-Agonists | 1 | 2015 | 358 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15102 | 0.030 |
Why?
|
Muscle Fibers, Slow-Twitch | 1 | 2013 | 55 | 0.030 |
Why?
|
Hypertrophy | 1 | 2015 | 560 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2011 | 10284 | 0.030 |
Why?
|
Muscle Fibers, Fast-Twitch | 1 | 2013 | 75 | 0.030 |
Why?
|
Osteogenesis | 2 | 1990 | 1276 | 0.030 |
Why?
|
Heart | 1 | 2006 | 4315 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 810 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2013 | 23437 | 0.030 |
Why?
|
Myography | 1 | 2014 | 105 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1369 | 0.030 |
Why?
|
Fractures, Stress | 1 | 1995 | 170 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2010 | 4981 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2015 | 683 | 0.030 |
Why?
|
|